B. Metzler Seel. Sohn & Co. Ag Abb Vie Inc. Transaction History

B. Metzler Seel. Sohn & Co. Ag

$10 Billion
Q3 2024

A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Abb Vie Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 452,807 shares of ABBV stock, worth $81.5 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

452,807

Previous 490,619 7.71%

Holding current value

$81.5 Million

Previous $84.2 Million 6.26%

% of portfolio

0.89%

Previous 0.89%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$163.84 - $199.33 $6.2 Million - $7.54 Million	-37,812 Reduced 7.71%	452,807 $89.4 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $5.25 Million - $6.13 Million	33,913 Added 7.43%	490,619 $84.2 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $11.9 Million - $13.5 Million	74,241 Added 19.41%	456,706 $83.2 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $3.93 Million - $4.43 Million	28,583 Added 8.08%	382,465 $59.3 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $997,917 - $1.16 Million	7,470 Added 2.16%	353,882 $52.7 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $2.99 Million - $3.72 Million	22,543 Added 6.96%	346,412 $46.7 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $9.25 Million - $10.7 Million	-63,986 Reduced 16.5%	323,869 $51.6 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $4.92 Million - $5.91 Million	35,604 Added 10.11%	387,855 $62.7 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $1.14 Million - $1.31 Million	-8,518 Reduced 2.36%	352,251 $47.3 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $1.22 Million - $1.55 Million	8,837 Added 2.51%	360,769 $55.3 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $10.4 Million - $12.9 Million	78,801 Added 28.85%	351,932 $57.1 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $29.3 Million - $37.1 Million	273,131 New	273,131 $37.1 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Ag with notifications on news.

Account

B. Metzler Seel. Sohn & Co. Ag Abb Vie Inc. Transaction History